Hyundai Bioscience
Clinical trials sponsored by Hyundai Bioscience, explained in plain language.
Hyundai Bioscience is a South Korean biotech company developing pharmaceuticals and health products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New dengue drug trial aims to shorten illness and lower virus levels Results expected Jan 2027 (estimated) 🚀 Make-or-break
- Old drug, new hope: niclosamide combo targets resistant prostate cancer Results expected Sep 2027 (estimated)